جست‌وجوی استاد و پژوهشگر

Patrizia Camellitiمشاهده پروفایل

مدرس ارشد

• Cardiovascular Disease
• Myocardial Slices
• Fibroblasts
• +۳ مورد دیگر

Dr. Patrizia Camelliti is a Senior Lecturer in Cardiovascular Molecular Science at the University of Surrey's School of Biosciences and Medicine, within the Faculty of Health and Medical Sciences. She holds a DPhil from the University of Oxford and is a Fellow of the Higher Education Academy (FHEA). Her research focuses on cardiac fibroblast-cardiomyocyte interactions, using advanced models like living myocardial slices and tissue-engineered systems. Key projects include investigating fibrosis, arrhythmogenesis, and regenerative therapies. Camelliti's educational background includes a Biological Sciences degree (magna cum laude) from the University of Milan, followed by a DPhil at Oxford under Professors Peter Kohl and Colin Green. She has held a Junior Research Fellowship at Oxford and secured grants like the EP Abraham Cephalosporin award. Her work emphasizes 3Rs principles (Replacement, Reduction, Refinement) in preclinical models. Teaching responsibilities include leading modules like BMS1025: Cell Biology for ~400 students, alongside courses in physiology and animal biology. Current PhD students supervised include Georgie Thompson, Berjaeu Officer, Chris Duringer, and Millie Trowbridge. Notable publications (2023–2024) highlight advancements in myocardial slice viability, antifibrotic therapies, and bioelectronic strategies for cardiac engineering. Awards include the Junior Research Fellowship and grants supporting her work on cardiac slice models and fibroblast modulation. Her lab collaborates internationally, promoting adoption of 3D slice models in academia and industry to reduce animal use while advancing human heart disease research.

Johannes Beckerمشاهده پروفایل

پژوهشگر

• Toxicology
• Environmental Health
• Air Pollution
• +۵ مورد دیگر

Johannes Becker is a researcher at the University of Rostock, affiliated with the Institute of Chemistry and the Department of Analytical Chemistry. He contributes to the EU-funded ULTRHAS project (Grant Agreement No. 955390), focusing on the health impacts of ultrafine particles (UFPs) from transportation sources. His research involves in vitro toxicity studies using human lung models at the air-liquid interface to assess the effects of combustion and non-exhaust emissions. These studies aim to understand how the chemical and physical properties of UFPs influence their toxicity, particularly in the alveolar regions of the lungs. His work adheres to the 3Rs principle (Replace, Reduce, Refine), utilizing advanced in vitro methods to generate physiologically relevant toxicological data while minimizing environmental impact. The ULTRHAS consortium includes partners such as the European Commission, University of Rostock, and the Norwegian Institute of Public Health. Although no publications or awards are listed in the provided text, his research aligns with environmental health, aerosol toxicology, and analytical chemistry. He collaborates under Dr. Sebastiano Di Bucchianico’s subgroup responsible for Work Package 3: Toxicity Screening of Various Modes of Transport in Air-Liquid Interface Lung Models . Contact details: Phone: +49 (0)381 498 - 6535 Email: johannes.becker@helmholtz-munich.de Address: Albert-Einstein-Straße 27, 18059 Rostock, Germany

Carrie Frieseمشاهده پروفایل

استاد

• Medical Sociology
• Science and Technology Studies
• Animal Studies
• +۷ مورد دیگر

Carrie Friese is a Professor in the Department of Sociology at the London School of Economics and Political Science (LSE), serving as Doctoral Programme Director. She specializes in Medical Sociology, Science and Technology Studies, and Animal Studies, with a focus on qualitative methodologies like Situational Analysis. Her research explores the intersections of human and non-human actors in biomedical settings, laboratory animal ethics, and the sociological implications of cloning and endangered species preservation. Dr. Friese has pioneered Situational Analysis alongside Adele Clarke and Rachel Washburn, emphasizing relational and mixed-methods approaches. Her educational background and career trajectory are not explicitly detailed in the text, but her extensive publications and research collaborations indicate advanced academic training in sociology and science studies. Key projects include a Wellcome Trust-funded study on laboratory animals and a Leverhulme Fellowship supporting her monograph on lab animal humanitarianism. Research interests include the ethics of care in translational medicine, the politics of invisibility in animal science, and the role of non-human actors in public health. Recent work involves co-leading an ESRC-funded project on mixed-methods data infrastructure for understanding social change impacts on individual lives. Friese teaches courses on the sociology of health, technology, and qualitative research methods. Her articles critically analyze topics like 'shadow bodies' of lab mice, the moral frameworks governing animal experimentation, and digital methods in situational analysis. She co-authored influential texts such as Situational Analysis: grounded theory after the interpretive turn and has contributed to debates on cloning, conservation ethics, and the future of endangered species. Though no specific awards are listed, her academic leadership roles and prolific publication record reflect significant scholarly recognition. Her work bridges sociology, science studies, and ethics, with implications for policy and practice in biomedical research and conservation biology.

• Pharmacology
• Cardiovascular Pharmacology
• G Protein-Coupled Receptors (GPCRs)
• +۱۲ مورد دیگر

Margaret Rose Cunningham is a Reader in Pharmacology and Associate Dean (Learning Enhancement) at the University of Strathclyde’s Faculty of Science, based in the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). She also serves as the Director of Biomolecular Science (BMS) Programmes, leading curriculum development and accreditation with IBMS and RSB. Her academic leadership extends to external examiner roles at Swansea University and University College Cork, and she is actively engaged in national and international pharmacology education initiatives through IUPHAR and the British Pharmacological Society. Her educational background includes a PhD in Molecular Pharmacology of Proteinase-activated receptors (PARs) and a Postgraduate Diploma in Academic Practice, both from the University of Strathclyde. She is a Senior Fellow of the Higher Education Academy (SFHEA), reflecting her commitment to pedagogical excellence. Cunningham's research centers on G protein-coupled receptors (GPCRs), particularly PARs and P2Y receptors, and their roles in cardiovascular function, inflammation, anti-cancer therapy-induced cardiotoxicity, and skeletal muscle aging. She co-led the Cardiovascular and Metabolic Diseases (CMVD) research group from 2017 to 2023. Her educational scholarship focuses on inclusive teaching practices and developing alternative, sustainable models to rodent-based pharmacology labs—such as 3D-printed human-body-on-a-chip systems—aligned with the 3Rs (Replacement, Reduction, Refinement). Her recent publications reflect a dual focus: advancing pharmacological knowledge in cancer and cardiovascular disease, and innovating in STEM education through OSPEs and inclusive assessment strategies. Her scientific contributions have been recognized with numerous awards, including the British Pharmacological Society Rang Prize for Teaching (2023), Honorary Fellowship of the BPS (2023), the AWERB 3Rs Prize (2024), and the Strathclyde Teaching Excellence Award. She is a Fellow of the Royal Society of Edinburgh Young Academy of Scotland and a Winston Churchill Memorial Trust Fellow. Fellow of the British Pharmacological Society (2021) Honorary Fellowship, British Pharmacological Society (2023) Rang Prize for Outstanding Achievement in Teaching, BPS (2023) AWERB 3Rs Prize (2024) Strathclyde Teaching Excellence Award (2024) Winston Churchill Memorial Trust Fellow (2017) Cunningham leads multiple research and educational projects, including the BPS-funded 'Revolutionising Pharmacology Education' initiative involving primary to postgraduate students, and grants from SCAF and BPS Summer Studentships. She supervises PhD students and has led Athena SWAN initiatives focused on career progression and gender equity in STEM. Her work contributes to UN Sustainable Development Goals, particularly in education and health equity. She is actively involved in professional service as a Reviewing Editor for Pharmacological Research & Perspectives , Secretary of the IUPHAR-Education Section, and member of BPS committees. Her outreach includes public engagement, organizing conferences, and mentoring through the RSE Young Academy of Scotland.

Eva Bay Wedebyeمشاهده پروفایل

استاد پژوهشی

• Quantitative Structure-Activity Relationships (QSAR)
• Toxicology
• Regulatory Toxicology
• +۳ مورد دیگر

Eva Bay Wedebye is a Senior Executive Officer and Head of the Research Group for Chemical Risk Assessment and GMO at the National Food Institute (Technical University of Denmark). Her work focuses on (Q)SAR modeling for toxicity prediction, regulatory compliance (e.g., REACH), and reducing animal testing. She leads projects like PARC and FREIA, advancing tools for endocrine disruption assessment. Education: PhD in Environmental Chemistry (University of Copenhagen, 1997). She advises on OECD frameworks and contributes to the (Q)SAR Application Toolbox. Her research emphasizes large-scale chemical screening, including the Danish Advisory List for Self-Classification. Key research areas include QSAR model development/validation, chemical risk assessment, and FAIR data practices. Over 75 publications span QSAR applications in toxicity, endocrine disruption, and regulatory science. Recognition: 2016 Danish 3R-Center Prize for reducing animal testing. Active in conferences and policy initiatives, such as the RACEMiC roadmap for chemical mixture risk assessment. Labs/Teams: Directs the National Food Institute Research Group, collaborating internationally on projects like ATHENA (thyroid hormone disruption) and LIFE CONCERT REACH (in silico modeling networks).

Nikolai Georgiev Nikolovمشاهده پروفایل

عضو هیئت علمی

• Quantitative Structure-Activity Relationships (Q)SARs
• Chemical Risk Assessment
• Toxicity Prediction
• +۳ مورد دیگر

Nikolai Georgiev Nikolov is a Senior Researcher at the National Food Institute, Technical University of Denmark, specializing in developing (Q)SAR models for chemical risk assessment. His work focuses on toxicity prediction, regulatory compliance, and reducing animal testing through computational methods. Education: Computer Science (Mathematical Logic), Sofia University, Bulgaria (1989–1995) Research Interests: He leads efforts in QSAR model development for endpoints like mutagenicity, carcinogenicity, and endocrine disruption. His group collaborates internationally to enhance regulatory acceptance of computational toxicology tools. Awards: 2016 Danish 3R-Center 3R Prize for reducing animal experimentation through QSAR advancements Projects: Key initiatives include the Danish (Q)SAR Database, REACH compliance frameworks, and the ATHENA project on thyroid hormone disruption. He has advised on OECD guidelines and contributed to the (Q)SAR Application Toolbox.

• Biomechanics
• Bone Mechanics
• Dental Prostheses
• +۵ مورد دیگر

Mara Terzini is an Associate Professor at the Department of Mechanical and Aerospace Engineering (DIMEAS), Polytechnic University of Turin, and a member of the PolitoBIOMed Lab - Biomedical Engineering Lab . Her research focuses on biomechanics , bone mechanics , dental prostheses , and medical device optimization , with expertise in experimental analysis , finite element modeling , and multibody simulation . Research Lines: Design of innovative ventilation systems, dynamic/fatigue analysis of biomechanical systems, mechanical characterization of soft tissues, structural analysis of bone-implant systems, study of orthopedic devices ERC Sectors: Computational engineering, Industrial bioengineering, Industrial design (product design, ergonomics) She has received notable awards including the Lifebility Award (2021) and Polytechnic University of Turin Quality Awards (2015). Her students include PhD candidates working on cardiovascular engineering, medical device innovation, and multiscale biomechanical modeling. Mara participates in editorial roles for journals like Frontiers in Medical Engineering and Materials , and serves on scientific committees for European and Italian biomechanics conferences. Her recent publications span topics from CPAP therapy mechanics to bone implant stability and tissue engineering.

Cory Millerمشاهده پروفایل

دانشیار

• Neuroscience
• Cognitive Neuroscience
• Behavioral Neuroscience
• +۶ مورد دیگر

Cory Miller is an Associate Professor in the Department of Psychology at the University of California, San Diego (UCSD), where he leads the Cortical Systems & Behavior Laboratory. His research focuses on understanding the cortical basis of behavior with an emphasis on species-typical natural behaviors in marmoset monkeys. Dr. Miller's work spans the continuum of sensory to motor processes, investigating sensory recognition, categorization, sensory-motor interactions, and decision-making through integrated approaches combining field and laboratory experiments with neural techniques such as single-unit neurophysiology. Dr. Miller's research program is organized around three primary projects: Social Communication, which examines the co-evolution of brain and behavior in marmoset vocal communication systems; Navigating Social Space, which investigates how primates represent both spatial position and social identity through medial temporal lobe structures; and Natural Vision, which explores active vision by studying marmosets as they hunt insects in naturalistic conditions. His lab leverages the unique advantages of the marmoset model, including its highly similar visual and oculomotor system to humans, recent development of transgenic lines, and smooth lissencephalic brain that facilitates neural recording. This approach provides novel platforms to examine the complex interplay between social, ecological, and neurobiological factors that contribute to primate behavior. Dr. Miller's publication record demonstrates a strong focus on naturalistic approaches to studying brain function, with recent work emphasizing active vision in freely moving marmosets, neural basis of vocal communication, and spatial navigation in primate hippocampus. His research shows a clear trajectory toward more ecologically valid paradigms that bridge the gap between controlled laboratory experiments and natural behavior, with increasing emphasis on cross-modal integration, social cognition, and ethologically relevant neural mechanisms. Dr. Miller's research is supported by multiple grants from prestigious funding sources: National Institute of Health grant R01 DC012097 Air Force Office of Scientific Research grant 19RT0316 National Institute of Health grant R01 NS109294 National Institute of Health grant U01 NS116377 National Institute of Health grant R01 NS118457 National Institute of Health grant U24 MH123423 Dr. Miller actively mentors the next generation of neuroscientists, currently advising graduate students Brendan Prendergast (researching the Cocktail Party Paradigm in marmosets) and Tim Tyree (studying computational efficiency of the visual system), along with postdoctoral fellows Vikram Pal Singh, Dori Grijseels, Jingwen Li, and Arthur Lefevre. His laboratory has trained numerous successful alumni who have gone on to academic and research positions, demonstrating his commitment to comprehensive scientific training and professional development. The Cortical Systems & Behavior Laboratory maintains strong collaborative relationships with researchers at The Salk Institute, particularly Ed Callaway and John Reynolds in Systems Neurobiology. The lab is affiliated with both the UCSD Psychology Graduate Program and the Neurosciences Graduate Program, providing interdisciplinary training opportunities for students interested in the neural basis of natural behavior. Dr. Miller's team of neuroscientists is dedicated to advancing our understanding of how cortical circuits support complex behavior in ecologically relevant contexts.

Christian Hiepenمشاهده پروفایل

استاد

• Molecular Biology
• Biomedicine
• Cellular Biomechanics
• +۱۹ مورد دیگر

Prof. Dr. Christian Hiepen is a faculty member at the Department of Engineering and Natural Sciences (FB 8) at Westfälische Hochschule, where he leads research in molecular cell biology, regenerative therapies, and biomedicine. He is affiliated with the Westfälisches Institut für Gesundheit and actively contributes to both teaching and research. His academic rank is Professor, and he is currently active with no indication of retirement or former status. His research focuses on understanding the molecular interactions of cells in health and disease, particularly in cardiovascular disorders and rare genetic diseases. He utilizes advanced 3D cell culture models such as organoids derived from induced pluripotent stem cells (iPSCs) to study disease mechanisms and develop new therapeutics. His work integrates molecular biology, biochemistry, cellular biomechanics, and engineering principles, with a special emphasis on BMP and TGFβ signaling pathways and their role in vascular biology and tissue regeneration. The recent publications highlight a strong trend in interdisciplinary research combining cell signaling, biomechanics, and tissue engineering. His team investigates how mechanical forces and genetic mutations interact to drive vascular pathologies, using cutting-edge techniques like confocal microscopy, microfluidic systems, and lab-on-chip technologies. The development and standardization of organoid models are central themes, reflecting a commitment to advancing alternative methods to animal testing (3R principles). Prof. Hiepen teaches a range of courses including Bioanalytics, Biomaterials and Tissue Engineering, Clinical Chemistry, and Cellular Biomechanics at both undergraduate and graduate levels. He mentors students and encourages interdisciplinary collaboration, particularly welcoming those interested in combining biology with engineering and computational methods in his research group. His laboratory employs a wide array of techniques, including qRT-PCR, Western blotting, immunocytochemistry, live-cell imaging, confocal microscopy, nanoindentation, and biosensor development. The integration of IT and algorithm development for data analysis underscores the computational dimension of his research. His work is published in high-impact journals such as Nature Communications, PLOS Biology, and Cells, demonstrating significant contributions to the fields of cell biology and biomedicine.

Volker Thielمشاهده پروفایل

استاد

• Virology
• Immunology
• Infectious Diseases
• +۵ مورد دیگر

Professor Volker Thiel serves as Directorate Co-Chair of the Multidisciplinary Center for Infectious Diseases (MCID) and Head of a Research Group at the Institute of Virology and Immunology (IVI) within the Vetsuisse Faculty of the University of Bern. His work bridges veterinary and human medicine through the One Health approach, focusing on highly contagious animal diseases and zoonotic pathogens. The IVI operates high-security laboratories in Mittelhäusern (risk level 4) and Bern (risk level 2), where Thiel's team conducts critical research on emerging infectious diseases. Thiel's research spans coronaviruses (including SARS-CoV-2 cloning and Omicron variant characterization), zoonotic pathogens (monkeypox, avian influenza), and animal diseases (African swine fever, BVD). His lab has developed innovative in vitro models for placental and brain tissue infection, contributed to understanding viral entry mechanisms, and pioneered nasal spray vaccine approaches. Recent work includes investigating H5N1 stability in dairy products (2024) and ASF immunity in pigs. Thiel leads the National Research Program 'Covid-19' (NFP 78) initiatives and directs the Multidisciplinary Center for Infectious Diseases established in 2021. His team's SARS-CoV-2 clone has been adopted globally for diagnostic testing, antiviral screening, and vaccine development. The EPIZONE Annual Conference 2026 in Bern, which he's involved with, highlights his leadership in European infectious disease networks. Director of Multidisciplinary Center for Infectious Diseases (MCID) Principal Investigator for Swiss National Science Foundation projects Coordinator of international collaborations with FLI, OIE/FAO, and EU Reference Laboratories Thiel mentors numerous doctoral researchers across virology specializations, with their work featured in the IVI Young Researchers blog. His lab participates in vaccine development consortia including RocketVax AG partnerships. Current projects focus on mucosal influenza vaccines, ASFV pathogenesis, and neurotropic potential of emerging viruses.

Toni Meisterمشاهده پروفایل

پژوهشگر

• Virology
• Infectious Diseases
• Public Health
• +۳ مورد دیگر

Toni Meister is a Researcher at the Institute for Infection Research and Vaccine Development (University Medical Center Hamburg-Eppendorf). Their work focuses on virology , infectious diseases , and public health , with particular emphasis on SARS-CoV-2 evolution under immunosuppressive treatments, viral inactivation methods, and host-pathogen interactions. Research Interests Dr. Meister investigates: Viral evolution in immunocompromised hosts Host entry factor regulation (ACE2/TMPRSS2) in SARS-CoV-2 infections MicroRNA-mediated viral pathogenesis Environmental viral stability (laundry, disinfectants) Hepatitis E virus replication dynamics Neuro-immune interactions in viral contexts Current projects include resCAPE (SARS-CoV-2 evolution under immunosuppression) and wastewater monitoring for hepatitis E variants. Their recent publications span virology, molecular biology, and hygiene policy. Labs & Collaborations AG Meister (research group) Neuro-Immune Network Hamburg 3R Research Framework Collaborations with Clinical Trial Office and Epidemiological Study Center

Laura Grace Bartlettمشاهده پروفایل

پژوهشگر ارشد

• Immunology
• Oncology
• Immunopathogenic diseases
• +۲ مورد دیگر

Dr Laura Grace Bartlett is a Research Fellow at the University of Southampton , currently working in the natural killer (NK) cell research group led by Dr Matthew D. Blunt. Her research focuses on identifying and optimising NK cell-derived therapeutics for haematological malignancies , with a secondary emphasis on immunopathogenic and inflammatory diseases . As a 3Rs Champion , she advocates for improved ethical standards in animal research through replacement, refinement, and reduction principles. BSc (Hons) in Forensic Biology (Molecular Biology) from Nottingham Trent University MSc and PhD in Microbiology and Immunology from the University of Nottingham Expertise in developing murine models for chronic obstructive pulmonary disease (COPD) and e-cigarette smoke exposure studies Her research integrates immunology , oncology , and microbiome interactions , with a recent publication analysing XPO1 inhibitors in targeted anti-tumor therapy. While her work primarily targets haematological malignancies , she also explores maternal/paternal smoking impacts on fetal development and long-term immunopathogenic effects of environmental exposures.

Simon Allisonمشاهده پروفایل

عضو هیئت علمی

• Cancer cell metabolism
• NAD+-dependent enzymes
• Molecular dependencies in cancer
• +۴ مورد دیگر

Dr. Simon Allison is a Reader in the Department of Physical and Life Sciences at the School of Applied Sciences, University of Huddersfield. He is a member of the Pharmacology and Therapeutics Centre and Associate Member of the Cellular and Molecular Models of Disease Centre. Education: B.A. in Biological Natural Sciences (First Class Honors) from University of Cambridge PhD in Cancer Biology from University of Glasgow His research focuses on cancer metabolism and NAD+-dependent enzymology , particularly the exploitation of cancer cell metabolic rewiring and molecular dependencies. He investigates sirtuins and epigenetic alterations in cancer cells, aiming to elucidate mechanisms of action of novel anti-cancer agents. Recent publications highlight his work on self-assembling cryptate compounds (2024), cannabinoid cytotoxicity (2023), and omega-3 derivatives in prostate cancer (2022). These studies demonstrate his interest in chemical biology approaches to cancer therapy. He currently serves as External PhD Examiner at University of Manchester and Secretary for the British Society for Cell Biology. His research is funded by Kidscan and the University of Huddersfield.

Andreas Holzingerمشاهده پروفایل

دانشیار

• Explainable AI
• Interpretable machine learning
• Health informatics
• +۳ مورد دیگر

Andreas Holzinger leads the Holzinger Group (HCAI, Human-Centered AI Lab) at the Institute for Medical Informatics/Statistics, Medical University Graz, and holds a venia docendi at TU Graz. He serves as consultant for multiple governments and scientific organizations and participates in the advisory boards of national AI strategies. PhD in Cognitive Science (Graz University, 1998) Habilitation in Applied Computer Science (TU Graz, 2003) His research focuses on Explainable AI , Interactive Machine Learning , and Human-in-the-Loop approaches within Health Informatics , combining Human-Computer Interaction and Knowledge Discovery . He founded the Expert Network HCI-KDD and organizes the IFIP Cross-Domain Conference CD-MAKE . His recent publications emphasize human-centric AI , medical data visualization , and interactive knowledge discovery , particularly in biomedical and clinical domains. He has contributed to gamification approaches in education technology and virtual patient applications. 2018 - Top 10 AI expert in Austria (IFIP WCC) 2018 - Elected Austrian Representative to IFIP TC 12 2017 - Invited Keynote at DATA 2017 2016 - Invited Keynote at KES Conference Andreas has participated in 30+ multinational R&D projects (€6M+ budget), published 300+ works (11k+ citations, h-index 48), and actively promotes cross-domain collaboration between AI and biomedical research.

Manasi Nandiمشاهده پروفایل

استاد

• Cardiovascular Pharmacology
• Physiological Waveform Analysis
• Sepsis Pathophysiology
• +۳ مورد دیگر

Professor Manasi Nandi holds a position as Professor in Integrative Pharmacology at King's College London, affiliated with the School of Cancer & Pharmaceutical Sciences and the Institute of Pharmaceutical Science. Her roles include leading research in cardiovascular pharmacology and physiological waveform analysis, with a focus on translating mathematical methodologies like Symmetric Projection Attractor Reconstruction (SPAR) into clinical applications. She collaborates with King's Health Partners, academic institutions, and industry to advance early detection of disease through waveform analysis. Affiliations: Department of Pharmacology & Therapeutics, Institute of Pharmaceutical Science Research Interests: Cardiovascular pharmacology, sepsis, nitric oxide pathways, and medical device development Her work spans drug discovery, preclinical model refinement, and interdisciplinary projects combining mathematics, engineering, and medicine. She leads the Humanising Healthcare podcast series, addressing healthcare inequities and AI bias. Nandi is also committed to education, having designed innovative courses and received awards for teaching excellence. Grants/Projects: EPSRC-funded SPARICT study on cardiac toxicity assessment, QUMPHY project on photoplethysmography signal analysis, and NC3Rs-funded SPARKS project. She has delivered numerous invited talks and contributed to policy initiatives on animal welfare and experimental protocols.